PPARγ Agonists Attenuate Trigeminal Neuropathic Pain
- PMID: 28514232
- PMCID: PMC5675763
- DOI: 10.1097/AJP.0000000000000509
PPARγ Agonists Attenuate Trigeminal Neuropathic Pain
Abstract
Objectives: The aim of this study is to investigate the role of peroxisome proliferator-activated receptor-gamma isoform (PPARγ), in trigeminal neuropathic pain utilizing a novel mouse trigeminal inflammatory compression (TIC) injury model.
Results: The study determined that the PPARγ nuclear receptor plays a significant role in trigeminal nociception transmission, evidenced by: 1) Intense PPARγ immunoreactivity is expressed 3 weeks after TIC nerve injury in the spinal trigeminal caudalis, the termination site of trigeminal nociceptive nerve fibers. 2) Systemic administration of a PPARγ agonist, pioglitazone (PIO), attenuates whisker pad mechanical allodynia at doses of 300 mg/kg i.p. and 600 mg/kg p.o. 3) Administration of a PPARγ antagonist, GW9662 (30 mg/kg i.p.), prior to providing the optimal dose of PIO (300 mg/kg i.p.) blocked the analgesic effect of PIO.
Discussion: This is the first study localizing PPARγ immunoreactivity throughout the brainstem trigeminal sensory spinal nucleus (spV) and its increase three weeks after TIC nerve injury. This is also the first study to demonstrate that activation of PPARγ attenuates trigeminal hypersensitivity in the mouse TIC nerve injury model. The findings presented here suggest the possibility of utilizing the FDA approved diabetic treatment drug, PIO, as a new therapeutic that targets PPARγ for treatment of patients suffering from orofacial neuropathic pain.
Figures





Similar articles
-
Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury.Clin J Pain. 2018 Feb;34(2):168-177. doi: 10.1097/AJP.0000000000000515. Clin J Pain. 2018. PMID: 28542026 Free PMC article.
-
Dysregulated TNFα promotes cytokine proteome profile increases and bilateral orofacial hypersensitivity.Neuroscience. 2015 Aug 6;300:493-507. doi: 10.1016/j.neuroscience.2015.05.046. Epub 2015 May 29. Neuroscience. 2015. PMID: 26033565 Free PMC article.
-
Bovine lactoferrin reduces extra-territorial facial allodynia/hyperalgesia following a trigeminal nerve injury in the rat.Brain Res. 2017 Aug 15;1669:89-96. doi: 10.1016/j.brainres.2017.04.015. Epub 2017 Apr 29. Brain Res. 2017. PMID: 28465227
-
Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain.Molecules. 2020 Mar 3;25(5):1120. doi: 10.3390/molecules25051120. Molecules. 2020. PMID: 32138198 Free PMC article. Review.
-
Non-neuronal cells act as crucial players in neuropathic orofacial pain.J Oral Biosci. 2024 Sep;66(3):491-495. doi: 10.1016/j.job.2024.07.005. Epub 2024 Jul 18. J Oral Biosci. 2024. PMID: 39032826 Review.
Cited by
-
A network pharmacology approach to predict potential targets and mechanisms of "Ramulus Cinnamomi (cassiae) - Paeonia lactiflora" herb pair in the treatment of chronic pain with comorbid anxiety and depression.Ann Med. 2022 Dec;54(1):413-425. doi: 10.1080/07853890.2022.2031268. Ann Med. 2022. PMID: 35098831 Free PMC article.
-
Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.Cancer. 2018 Jun 1;124(11):2289-2298. doi: 10.1002/cncr.31248. Epub 2018 Feb 20. Cancer. 2018. PMID: 29461625 Free PMC article. Review.
-
PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress.BMC Gastroenterol. 2025 Jan 20;25(1):22. doi: 10.1186/s12876-025-03618-3. BMC Gastroenterol. 2025. PMID: 39833676 Free PMC article.
-
Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool.Front Neurosci. 2019 Aug 28;13:907. doi: 10.3389/fnins.2019.00907. eCollection 2019. Front Neurosci. 2019. PMID: 31555078 Free PMC article. Review.
-
Sustained relief of trigeminal neuropathic pain by a blood-brain barrier penetrable PPAR gamma agonist.Mol Pain. 2019 Jan-Dec;15:1744806919884498. doi: 10.1177/1744806919884498. Mol Pain. 2019. PMID: 31588847 Free PMC article.
References
-
- Zakrzewska JM. Differential diagnosis of facial pain and guidelines for management. Br J Anaesth. 2013;111:95–104. - PubMed
-
- Asmundson GJ, Katz J. Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety. 2009;26:888–901. - PubMed
-
- De Leeuw R. Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management. 4. Hanover Park, IL: Quintessence Publishing Co, Inc; 2008. p. 316.
-
- Robinson MJ, Edwards SE, Iyengar S, Bymaster F, Clark M, Katon W. Depression and pain. Front Biosci (Landmark Ed) 2009;14:5031–51. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical